NASDAQ
Actinogen Medical Limited (ATGGF) has a free cash flow growth of 23.71% as of Friday, May 29, 2026. This represents a 116.11% increase compared to its 12-month average of -147.23%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.